Researchers from Nanjing University report details of new studies and findings in the area of pathology
2009 JUL 6 - (NewsRx.com) -- According to a study from Nanjing, People's Republic of China, "This study retrospectively reviewed the clinicopathological features of thymic epithelial tumors in 108 patients, and evaluated World Health Organization (WHO) histologic classification of thymic tumors. Other prognostic factors, including age, gender, clinical stage, and completeness Of tumor resection were also analyzed." "Seven type A tumors, 19 type AB, 23 type B1, 19 type B2, 27 type B3, and 13 thymic carcinomas were studied. The 5-year and 10-year Survival rates were 100% after resection Of tumor types A and AB; 93% and 81% for B1; 83% and 70% for B2; and 43% and 33% for B3. The overall 5-year and 10-year Survival rates were 72.0% and 63.0%, respectively. Tumor classification was highly significant in predicting Survival (P << .001) and also reflected the clinical behavior of tumors. The Masaoka stage was the most important independent prognostic index in thymomas," wrote H.L. Yin and colleagues, Nanjing University. The researchers concluded: "The WHO histologic subtype and completeness of resection were also important prognostic factors." Yin and colleagues published the results of their research in International Journal of Surgical Pathology (The Correlation of the World Health Organization Histologic Classification of Thymic Epithelial Tumors and Its Prognosis: A Clinicopathologic Study of 108 Patients From China. International Journal of Surgical Pathology, 2009;17(3):255-261). For additional information, contact H.L. Yin, Nanjing University, Dept. of Pathology, Jinling Hospital, School Medical, Nanjing 210002, People's Republic of China. The publisher of the International Journal of Surgical Pathology can be contacted at: Sage Publications Inc., 2455 Teller Rd., Thousand Oaks, CA 91320, USA. Keywords: People's Republic of China, Nanjing, Gender Health, Gender Medicine, Oncology, Pathology, Surgery, Thymic Cancer, Thymic Carcinoma, Thymoma, Women's Health, Nanjing University. This article was prepared by Clinical Oncology Week editors from staff and other reports. Copyright 2009, Clinical Oncology Week via NewsRx.com.
|
